These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
177 related articles for article (PubMed ID: 11739080)
1. Role of IGF-I and IGFBPs in the changes of mass and phenotype induced in rat soleus muscle by clenbuterol. Awede BL; Thissen JP; Lebacq J Am J Physiol Endocrinol Metab; 2002 Jan; 282(1):E31-7. PubMed ID: 11739080 [TBL] [Abstract][Full Text] [Related]
2. Molecular impact of clenbuterol and isometric strength training on rat EDL muscles. Mounier R; Cavalié H; Lac G; Clottes E Pflugers Arch; 2007 Jan; 453(4):497-507. PubMed ID: 17093970 [TBL] [Abstract][Full Text] [Related]
3. Clenbuterol treatment affects myosin heavy chain isoforms and MyoD content similarly in intact and regenerated soleus muscles. Bricout VA; Serrurier BD; Bigard AX Acta Physiol Scand; 2004 Mar; 180(3):271-80. PubMed ID: 14962009 [TBL] [Abstract][Full Text] [Related]
4. Skeletal muscle IGF-binding protein-3 and -5 expressions are age, muscle, and load dependent. Spangenburg EE; Abraha T; Childs TE; Pattison JS; Booth FW Am J Physiol Endocrinol Metab; 2003 Feb; 284(2):E340-50. PubMed ID: 12397024 [TBL] [Abstract][Full Text] [Related]
5. IGF and myostatin pathways are respectively induced during the earlier and the later stages of skeletal muscle hypertrophy induced by clenbuterol, a β₂-adrenergic agonist. Abo T; Iida RH; Kaneko S; Suga T; Yamada H; Hamada Y; Yamane A Cell Biochem Funct; 2012 Dec; 30(8):671-6. PubMed ID: 22696074 [TBL] [Abstract][Full Text] [Related]
6. The role of insulin-like growth factor I in clenbuterol-stimulated growth in growing lambs. Young OA; Watkins S; Oldham JM; Bass JJ J Anim Sci; 1995 Oct; 73(10):3069-77. PubMed ID: 8617679 [TBL] [Abstract][Full Text] [Related]
7. Expression of insulin-like growth factor I, insulin-like growth factor binding proteins, and collagen mRNA in mechanically loaded plantaris tendon. Olesen JL; Heinemeier KM; Haddad F; Langberg H; Flyvbjerg A; Kjaer M; Baldwin KM J Appl Physiol (1985); 2006 Jul; 101(1):183-8. PubMed ID: 16782835 [TBL] [Abstract][Full Text] [Related]
8. The expressions of insulin-like growth factors, their receptors, and binding proteins are related to the mechanism regulating masseter muscle mass in the rat. Matsumoto T; Akutsu S; Wakana N; Morito M; Shimada A; Yamane A Arch Oral Biol; 2006 Jul; 51(7):603-11. PubMed ID: 16513081 [TBL] [Abstract][Full Text] [Related]
9. Skeletal muscle myosin heavy chain isoforms and energy metabolism after clenbuterol treatment in the rat. Rajab P; Fox J; Riaz S; Tomlinson D; Ball D; Greenhaff PL Am J Physiol Regul Integr Comp Physiol; 2000 Sep; 279(3):R1076-81. PubMed ID: 10956268 [TBL] [Abstract][Full Text] [Related]
10. Decreased monocarboxylate transporter 1 in rat soleus and EDL muscles exposed to clenbuterol. Kitaura T; Tsunekawa N; Hatta H J Appl Physiol (1985); 2001 Jul; 91(1):85-90. PubMed ID: 11408417 [TBL] [Abstract][Full Text] [Related]
11. Regulation of IGF-I, IGFBP-4 and IGFBP-5 gene expression by loading in mouse skeletal muscle. Awede B; Thissen J; Gailly P; Lebacq J FEBS Lett; 1999 Nov; 461(3):263-7. PubMed ID: 10567708 [TBL] [Abstract][Full Text] [Related]
12. Elevated IGF-II mRNA and phosphorylation of 4E-BP1 and p70(S6k) in muscle showing clenbuterol-induced anabolism. Sneddon AA; Delday MI; Steven J; Maltin CA Am J Physiol Endocrinol Metab; 2001 Oct; 281(4):E676-82. PubMed ID: 11551843 [TBL] [Abstract][Full Text] [Related]
13. Clenbuterol induces expression of multiple myosin heavy chain isoforms in rat soleus fibres. Oishi Y; Imoto K; Ogata T; Taniguchi K; Matsumoto H; Roy RR Acta Physiol Scand; 2002 Dec; 176(4):311-8. PubMed ID: 12444937 [TBL] [Abstract][Full Text] [Related]
14. Effects of clenbuterol on contractile and biochemical properties of skeletal muscle. Dodd SL; Powers SK; Vrabas IS; Criswell D; Stetson S; Hussain R Med Sci Sports Exerc; 1996 Jun; 28(6):669-76. PubMed ID: 8784754 [TBL] [Abstract][Full Text] [Related]
15. Expression of the insulin-like growth factor system in the hypokalemic rat kidney. Rohan RM; Unterman TG; Liu L; Hise MK Am J Physiol; 1997 May; 272(5 Pt 2):F661-7. PubMed ID: 9176378 [TBL] [Abstract][Full Text] [Related]
16. Possible involvement of IGF-1 receptor and IGF-binding protein in insulin-induced enhancement of noradrenaline response in diabetic rat aorta. Kobayashi T; Kaneda A; Kamata K Br J Pharmacol; 2003 Sep; 140(2):285-94. PubMed ID: 12970107 [TBL] [Abstract][Full Text] [Related]
17. Protective Effects of Clenbuterol against Dexamethasone-Induced Masseter Muscle Atrophy and Myosin Heavy Chain Transition. Umeki D; Ohnuki Y; Mototani Y; Shiozawa K; Suita K; Fujita T; Nakamura Y; Saeki Y; Okumura S PLoS One; 2015; 10(6):e0128263. PubMed ID: 26053620 [TBL] [Abstract][Full Text] [Related]
18. A physiological level of clenbuterol does not prevent atrophy or loss of force in skeletal muscle of old rats. Chen KD; Alway SE J Appl Physiol (1985); 2000 Aug; 89(2):606-12. PubMed ID: 10926644 [TBL] [Abstract][Full Text] [Related]
19. Clenbuterol-induced fiber type transition in the soleus of adult rats. Criswell DS; Powers SK; Herb RA Eur J Appl Physiol Occup Physiol; 1996; 74(5):391-6. PubMed ID: 8954285 [TBL] [Abstract][Full Text] [Related]